![Pharmacology / Gadolinium / Gadopentetic acid / Drug safety / Gadoteric acid / Nephrogenic systemic fibrosis / Magnetic resonance imaging / Food and Drug Administration / Gadodiamide / Chemistry / Medicine / Matter Pharmacology / Gadolinium / Gadopentetic acid / Drug safety / Gadoteric acid / Nephrogenic systemic fibrosis / Magnetic resonance imaging / Food and Drug Administration / Gadodiamide / Chemistry / Medicine / Matter](https://www.pdfsearch.io/img/434ff9bff4821d8daad51ff761a77f19.jpg)
| Open Document File Size: 2,92 MBShare Result on Facebook
City Reference / / Company Guerbet LLC / / Country United States / / Event FDA Phase / Product Issues / / Facility Laboratory Findings / / IndustryTerm gadolinium containing products / magnetic resonance imaging / drug product / / MedicalCondition acute kidney injury / chronic severe kidney disease / inflammation / Nephrogenic Systemic Fibrosis / stroke / metastatic brain tumors / / MedicalTreatment relaxation / / Organization FDA / FDA Advisory Committee / National Science Foundation / Advisory Committee / PDUFA Goal Date Division / / Person Barbara A. Stinson / / Position representative / / Product Magnevist / Omniscan / Prohance / Multihance / Optimark / CNS / US / renal function / / Technology Pharmacokinetics / Pharmacodynamics / magnetic resonance imaging / tomography / MRI / Medical Imaging / /
SocialTag |